Reactome: A Curated Pathway Database
Attention
The EBI data centre will be shutting down from the afternoon (BST) of Friday 26th August until the afternoon of Tuesday 30th August 2016 for essential maintenance. This might have an impact on some Reactome services and we apologize for any inconvenience.

Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB

Stable Identifier
R-HSA-141333
Type
Pathway
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Summation

Human monoamine oxidases (MAOs) are flavin-containing enzymes that are present on the outer mitochondrial membrane and act on primary, secondary and tertiary amines. In contrast to the P450s which have a large number of isozymes, MAOs number only two isozymes, MAO-A and MAO-B. These gene products share over 70% sequence identity, are approximately 59KDa in size and have overlapping substrates (for example dopamine, tryamine and tryptamine) but each form also has distinct substrate specificities. MAO-A (primary type in fibroblasts) preferentially oxidises serotonin (5-Hydroxytryptamine) whereas MAO-B (primary type in platelets) prefers phenylethylamine. MAOs are of particular clinical interest because of the use of MAO inhibitors (MAOI) as antidepressants or in the treatment of neurodegenerative diseases Benedetti 2001, Beedham 1997).

Literature References
PubMed ID Title Journal Year
11468017 Biotransformation of xenobiotics by amine oxidases Fundam Clin Pharmacol 2001
9443166 The role of non-P450 enzymes in drug oxidation Pharm World Sci 1997
Participants
Participant Of
Orthologous Events
Cross References
BioModels Database